UNSPSC 51382304: Niflumic acid

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C13H9F3N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4U5MP5IUD8, chemically known as 3-pyridinecarboxylic acid, 2-((3-(trifluoromethyl)phenyl)amino)- but generally known as niflumic acid, which bears US NIH Compound Identifier 4488. European Medicines Agency schedules Niflumic acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09257MIG.

UNSPSC 51382304 Niflumic acid (Commodity) shows a significant mismatch between its nominal scope and the actual work state and local governments are currently soliciting under this code. The single recent opportunity in the dataset is Seminole County, Florida's IFB for Naloxone and Safe Drug Deactivation Systems — procurement of emergency opioid-reversal medication and drug disposal equipment for community health initiatives, not niflumic acid, which is a nonsteroidal anti-inflammatory pharmaceutical ingredient. The code appears to be mistagged on this solicitation and does not reflect authentic demand for the commodity as named.

No other recent state and local contract opportunities are present in the dataset under this code. The mismatch between the code's pharmaceutical classification and the Seminole County opportunity (which concerns naloxone, a wholly different active ingredient and therapeutic class) suggests either a data entry error in the opportunity's UNSPSC tagging or that this commodity code sees minimal genuine procurement activity from state and local buyers. Business development professionals should treat this code as dormant for state and local work unless additional corroborating opportunities emerge under the correct UNSPSC classification for naloxone-based products or drug deactivation systems.